Patents by Inventor Richard W. Franck

Richard W. Franck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8883745
    Abstract: The invention is directed to novel synthetic C-glycolipids that selectively induce a ThI-type immune response characterized by enhanced IL-12 secretion and increased activation of dendritic cells. The compounds of the invention are thereby useful in treating infections, cancers, cell proliferative disorders, and autoimmune diseases, both directly and as adjuvants.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: November 11, 2014
    Assignees: New York University, The Aaron Diamond Aids Research Center For The City Of New York, Research Foundation Of The City University Of New York
    Inventors: Moriya Tsuji, Guangwu Chen, Richard W. Franck, Guangli Yang
  • Publication number: 20100233207
    Abstract: The invention is directed to novel synthetic C-glycolipids that selectively induce a ThI-type immune response characterized by enhanced IL-12 secretion and increased activation of dendritic cells. The compounds of the invention are thereby useful in treating infections, cancers, cell proliferative disorders, and autoimmune diseases, both directly and as adjuvants.
    Type: Application
    Filed: May 22, 2007
    Publication date: September 16, 2010
    Applicants: New York University, Research Foundation of the City University of New York, The Aaron Diamond AIDS Research Center for the City of New York, Inc.
    Inventors: Moriya Tsuji, Guangwu Chen, Richard W. Franck, Guangli Yang
  • Publication number: 20020128214
    Abstract: A C-glucosyl ether lipid of the following formula: 1
    Type: Application
    Filed: December 11, 2001
    Publication date: September 12, 2002
    Inventors: Robert Bittman, Gilbert Arthur, Richard W. Franck